Apretude is a long-acting injectable medication used for HIV pre-exposure prophylaxis (PrEP). Planned Parenthood will offer ...

What kind of uptake can Gilead Sciences expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) ...

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...

While many big drug companies do amazing things for humanity, they’re also often vilified for profiteering from their work. This month, New York-listed Gilead Sciences has, not for the first time, ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The US Food and Drug Administration (FDA) has approved Gilead Science’s Yeztugo for the prevention of human immunodeficiency ...

Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...

FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...